GL Pharm Tech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,036	4,258	4,136	4,639	6,189
Cash & Short-Term Investments	3,036	4,258	4,136	4,639	6,189
Cash Growth	-28.69%	2.95%	-10.86%	-25.03%	-34.78%
Accounts Receivable	7,108	5,804	5,618	5,514	3,480
Other Receivables	151.41	214.16	173.99	156.25	180.71
Receivables	7,259	6,018	5,792	5,671	3,660
Inventory	10,956	8,550	6,640	5,508	3,387
Prepaid Expenses	3.19	5.39	2.14	-	0.2
Other Current Assets	411.62	182.28	49.21	372.14	32.77
Total Current Assets	21,666	19,014	16,619	16,190	13,270
Property, Plant & Equipment	20,740	18,127	18,864	19,850	15,465
Long-Term Investments	3,289	3,012	2,992	3,020	1,024
Other Intangible Assets	527.43	780.33	819.28	1,043	1,253
Long-Term Deferred Charges	786.59	899.65	208.33	435.8	663.27
Other Long-Term Assets	1,805	573.19	189.61	144.75	121.3
Total Assets	48,814	42,440	39,868	40,854	31,895
Accounts Payable	2,478	1,970	2,564	3,104	623.4
Accrued Expenses	1,273	700.45	1,017	1,707	645
Short-Term Debt	6,842	2,983	4,380	2,030	1,980
Current Portion of Long-Term Debt	7,400	5,697	2,000	4,350	249.96
Current Portion of Leases	86.36	92.46	77.92	71.68	88.82
Current Unearned Revenue	150	150	335	50	-
Other Current Liabilities	3,215	2,320	1,945	1,790	1,278
Total Current Liabilities	21,444	13,914	12,319	13,104	4,865
Long-Term Debt	4,180	5,650	11,247	7,400	5,450
Long-Term Leases	224.47	227.49	79.94	57.92	109.94
Long-Term Unearned Revenue	693.8	893.8	943.07	1,313	1,032
Pension & Post-Retirement Benefits	279.51	77.21	992.31	689.01	715.74
Long-Term Deferred Tax Liabilities	2,074	2,010	2,005	2,200	2,243
Other Long-Term Liabilities	0	0	-0	0	0
Total Liabilities	28,895	22,772	27,586	24,764	14,415
Common Stock	7,755	7,697	6,235	6,210	6,185
Additional Paid-In Capital	34,299	34,067	25,615	25,558	25,795
Retained Earnings	-22,149	-22,111	-19,251	-15,502	-15,313
Treasury Stock	-0.11	-0.11	-0.11	-0.11	-0.11
Comprehensive Income & Other	14.2	14.91	-317.23	-175.7	182.01
Total Common Equity	19,919	19,668	12,282	16,090	16,849
Minority Interest	-	-	-	-	630.18
Shareholders' Equity	19,919	19,668	12,282	16,090	17,480
Total Liabilities & Equity	48,814	42,440	39,868	40,854	31,895
Total Debt	18,733	14,650	17,785	13,910	7,879
Net Cash (Debt)	-15,697	-10,393	-13,650	-9,270	-1,690
Net Cash Per Share	-	-137.83	-219.33	-149.46	-33.23
Filing Date Shares Outstanding	-	76.97	62.35	62.1	61.85
Total Common Shares Outstanding	-	76.97	62.35	62.1	61.85
Working Capital	222.22	5,100	4,301	3,086	8,404
Book Value Per Share	-	255.54	196.98	259.09	272.40
Tangible Book Value	19,391	18,888	11,463	15,047	15,596
Tangible Book Value Per Share	-	245.40	183.84	242.29	252.15
Land	10,266	10,266	10,266	10,266	9,491
Buildings	7,530	7,530	7,530	7,530	4,417
Machinery	9,194	8,727	8,674	8,180	8,130
Construction In Progress	541.67	15.85	-	200	254

Source: S&P Global Market Intelligence. Standard template. Financial Sources.